Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro

Go back to Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro
(NASDAQ: MOLN) Delayed: 6.86 -0.02 (0.29%)
Previous Close $6.88    52 Week High
Open $7.27    52 Week Low
Day High $7.27    P/E N/A 
Day Low $6.72    EPS
Volume 82,146       

(NASDAQ: MOLN) Delayed: 6.86 -0.02 (0.29%)
Previous Close $6.88    52 Week High
Open $7.27    52 Week Low
Day High $7.27    P/E N/A 
Day Low $6.72    EPS
Volume 82,146